ID27596A - CRYSTAL PAROXSETINE FORM - Google Patents

CRYSTAL PAROXSETINE FORM

Info

Publication number
ID27596A
ID27596A IDW20001813A ID20001813A ID27596A ID 27596 A ID27596 A ID 27596A ID W20001813 A IDW20001813 A ID W20001813A ID 20001813 A ID20001813 A ID 20001813A ID 27596 A ID27596 A ID 27596A
Authority
ID
Indonesia
Prior art keywords
paroxsetine
crystal
paroxsetine form
crystal paroxsetine
Prior art date
Application number
IDW20001813A
Other languages
Indonesian (id)
Inventor
Andrew Simon Craig
Neal Ward
Wilson Mcilwaile
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9805581.7A external-priority patent/GB9805581D0/en
Priority claimed from GBGB9813054.5A external-priority patent/GB9813054D0/en
Priority claimed from GBGB9817115.0A external-priority patent/GB9817115D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of ID27596A publication Critical patent/ID27596A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IDW20001813A 1998-03-16 1999-03-16 CRYSTAL PAROXSETINE FORM ID27596A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9805581.7A GB9805581D0 (en) 1998-03-16 1998-03-16 Novel compounds
GBGB9813054.5A GB9813054D0 (en) 1998-06-17 1998-06-17 Novel compounds
GBGB9817115.0A GB9817115D0 (en) 1998-08-06 1998-08-06 Novel compounds

Publications (1)

Publication Number Publication Date
ID27596A true ID27596A (en) 2001-04-12

Family

ID=27269245

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20001813A ID27596A (en) 1998-03-16 1999-03-16 CRYSTAL PAROXSETINE FORM

Country Status (18)

Country Link
EP (1) EP1064282A1 (en)
JP (1) JP2002506865A (en)
KR (1) KR20010041947A (en)
CN (1) CN1300286A (en)
AP (1) AP2000001907A0 (en)
AU (1) AU2847199A (en)
BG (1) BG104839A (en)
BR (1) BR9908825A (en)
CA (1) CA2323896A1 (en)
EA (1) EA200000946A1 (en)
HU (1) HUP0101215A3 (en)
ID (1) ID27596A (en)
IL (1) IL138390A0 (en)
NO (1) NO20004583L (en)
PL (1) PL342931A1 (en)
SK (1) SK13622000A3 (en)
TR (1) TR200002675T2 (en)
WO (1) WO1999047519A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH689805A8 (en) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Paroxetine methanesulfonate, process for its preparation and pharmaceutical compositions containing it.
GB9919052D0 (en) * 1999-08-12 1999-10-13 Smithkline Beecham Plc Novel compound composition and process
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
EP0223403B1 (en) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidine derivative, its preparation, and its use as medicament
SK283608B6 (en) * 1995-02-06 2003-10-07 Smithkline Beecham Plc New forms of parotexin hydrochloride

Also Published As

Publication number Publication date
NO20004583D0 (en) 2000-09-14
JP2002506865A (en) 2002-03-05
KR20010041947A (en) 2001-05-25
BG104839A (en) 2001-09-28
HUP0101215A3 (en) 2002-05-28
TR200002675T2 (en) 2000-12-21
NO20004583L (en) 2000-09-15
WO1999047519A1 (en) 1999-09-23
SK13622000A3 (en) 2001-03-12
AU2847199A (en) 1999-10-11
CN1300286A (en) 2001-06-20
IL138390A0 (en) 2001-10-31
HUP0101215A2 (en) 2002-04-29
EP1064282A1 (en) 2001-01-03
CA2323896A1 (en) 1999-09-23
BR9908825A (en) 2000-11-21
PL342931A1 (en) 2001-07-16
EA200000946A1 (en) 2001-02-26
AP2000001907A0 (en) 2000-09-30

Similar Documents

Publication Publication Date Title
ID25660A (en) TERIPATIDE CRYSTAL
ID25534A (en) GLUCAGON-LIKE CRYSTAL PEPTIDES-1
DK1062480T3 (en) gyroscope
DK1070058T3 (en) (4-Arylsulfonylamino) tetrahydropyran-4-carboxylsyrehydroxamider
FI981234A0 (en) Align Order
MX225999B (en) ANTIFUNGIC CRYSTAL POLYMORPH.
ID23458A (en) NEFAZODON AVAILABLE FORM
ID26514A (en) CRYSTAL WELLS
ID23761A (en) SUBSTITUTED TRISICLIC
ID28779A (en) CRYSTAL FORMS OF EtO2C-CH2- (R) CgL-Aze-Pab-OH
DE69839563D1 (en) CARBOHYDRATE-NETWORKED GLYCOPROTEIN CRYSTALS
ID24221A (en) PATRUM PLACE
DK1064519T3 (en) Toxset gyroscope
ID23219A (en) SUBSTITUTED TRISICLIC
DK0969233T3 (en) Strömning Limits
PT779859E (en) ORIENTED CRYSTAL SETS
DE59905139D1 (en) structural element
DE69930205D1 (en) Crystal gap device
DE69801549D1 (en) Dovetail liquid crystal compound
DK1082575T3 (en) Anhydrous crystals
DE69710146D1 (en) Crystal holder
DE69823908D1 (en) single crystal
NO970910D0 (en) Spirostanylglykosidal crystals
DE69935146D1 (en) NONLINEAR OPTICAL CRYSTAL
ID27596A (en) CRYSTAL PAROXSETINE FORM